Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol and Behavioral Manipulation for Misophonia
NCT05928689Phase 1Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jun 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of propranolol in misophonia (5 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoints: Galvanic Skin Response at 1 month, Heart Rate at 1 month and 1 more. Started Jun 2023; status: completed.
02
Drugs
propranolol
03
Conditions
misophonia
Beyond the preview
Go deeper on NCT05928689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05928689.